Life Sciences Advisors

Wayne P. Yetter — ProActive for Patients Media

Wayne P. Yetter is executive Chairman of ProActive for Patients Media, Inc., an early investment stage company providing a physician-to-patient messaging system to increase patient adherence to medication therapies. Wayne served as Chief Executive Officer of Verispan LLC, a joint venture of McKesson Corp. and Quintiles Transnational, a leading provider of healthcare information and marketing services to the pharmaceutical industry, from September 2005 to August 2008 when the company was acquired by SDI Health. Wayne had a 30 year career in the pharmaceutical industry and held executive positions at Pfizer, Merck, Astra-Merck (now AstraZeneca) and Novartis. His roles included Vice President, Marketing Operations (global) and Vice President, Far East and Pacific at Merck, founding Chief Executive Officer of Astra-Merck, and President and Chief Executive Officer of Novartis Pharmaceuticals Corporation, the US division of Novartis AG.

Wayne also served as Chief Operating Officer of IMS Health, a market research data company from 1999 until 2000, when he became Chairman and Chief Executive Officer of Synavant, Inc. (a Nasdaq listed spin-out of IMS). Synavant was acquired by Dendrite International in 2003. Wayne currently Chairman of the Board of NuPathe Inc. and also serves as a director of EpiCept Corporation, InfuSystem Holdings, Inc. and SDIX. Previously, he served as Chairman of Noven Pharmaceuticals, Chairman of Transkaryotic Therapies, and Lead Independent Director of Matria Healthcare (each of these companies was acquired) and a director of Synvista Therapeutics. He served on the Executive Committee of PhRMA, the pharmaceutical industry association, from 1997-1999. Wayne holds a B.A. in Biology from Wilkes University and an M.B.A from Bryant University.